Melissa C. Larson
Impact in
- Reproductive Medicine top 5%
- Ovarian cancer diagnosis and treatment
- Oncology top 10%
- PARP inhibition in cancer therapy
Papers in
-
- Lymphoma Diagnosis and Treatment 31
-
- Cancer-related molecular mechanisms research 13
- Co-authors
- Ellen L. GoodeBrooke L. FridleyFranklin H. SimJulie M. CunninghamBahtiyar DemiralpEduardo N. NovaisPeter S. RoseKimberly R. Kalli
- Journals
- Blood (14 papers)Journal of Clinical Oncology (5 papers)American Journal of Hematology (5 papers)British Journal of Haematology (3 papers)Scientific Reports (3 papers)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Melissa C. Larson
73 papers receiving 1000 citations
Peers
Comparison fields: 5 of 89
- Reproductive Medicine 118
- Oncology 354
- Cancer Research 177
- Pathology and Forensic Medicine 206
- Genetics 103
Countries citing papers authored by Melissa C. Larson
This map shows the geographic impact of Melissa C. Larson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa C. Larson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa C. Larson more than expected).
Fields of papers citing papers by Melissa C. Larson
This network shows the impact of papers produced by Melissa C. Larson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa C. Larson. The network helps show where Melissa C. Larson may publish in the future.
Co-authors
The 25 scholars most cited alongside Melissa C. Larson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 6 | |
| 6 | 2023 | 33 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 2 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 7 | |
| 12 | 2021 | 13 | |
| 13 | 2021 | 10 | |
| 14 | 2020 | 20 | |
| 15 | 2019 | 22 | |
| 16 | 2019 | 17 | |
| 17 | 2019 | 3 | |
| 18 | The rps10 gene as a new barcode locus for oomycetes and its utility in metagenomics studies of environmental samples | 2019 | 1 |
| 19 | 2019 | 13 | |
| 20 | 2018 | 20 |
About Melissa C. Larson
Melissa C. Larson is a scholar working on Pathology and Forensic Medicine, Cancer Research, Reproductive Medicine, Oncology and Genetics, having authored 77 papers that have together received 1.0k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (31 papers), Cancer-related molecular mechanisms research (13 papers), Ovarian cancer diagnosis and treatment (9 papers), Chronic Lymphocytic Leukemia Research (8 papers), Viral-associated cancers and disorders (8 papers), Epigenetics and DNA Methylation (7 papers), Cancer survivorship and care (7 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). The work is most often cited by research in Reproductive Medicine (118 citations), Oncology (354 citations), Cancer Research (177 citations), Pathology and Forensic Medicine (206 citations) and Genetics (103 citations). Melissa C. Larson has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Ellen L. Goode, Brooke L. Fridley, Franklin H. Sim, Julie M. Cunningham, Bahtiyar Demiralp, Eduardo N. Novais, Peter S. Rose, Kimberly R. Kalli, James R. Cerhan and Thomas M. Habermann. Their work appears in journals such as Blood, Journal of Clinical Oncology, American Journal of Hematology, British Journal of Haematology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.